Search
for
Sort by
Research 661–690 of 1000+
- Prefrontal 5α-reductase 2 mediates male-specific acute stress response
- Role of janus kinase inhibitors in the treatment of alopecia areata
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Low-Dose IL-2 for Treating Moderate to Severe Alopecia Areata: A 52-Week Multicenter Prospective Placebo-Controlled Study Assessing its Impact on T Regulatory Cell and NK Cell Populations
- Hedgehog Pathway Inhibitors against Tumor Microenvironment
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Androgen Receptor Inhibitors in the Treatment of Acne Vulgaris: Efficacy and Safety Profiles of Clascoterone 1% Cream
- Wound healing with topical BRAF inhibitor therapy in a diabetic model suggests tissue regenerative effects
- Hair Loss Induced by Tumor Necrosis Factor Alpha Inhibitors
- Risk of Autoimmune Skin Diseases Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis Using the FAERS Database
- CGF therapy: bridging androgenetic alopecia observations to psoriasis treatment via IL-17 pathway
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- The Immunological Impact of IL-1 Family Cytokines on the Epidermal Barrier
- Simultaneous improvement of alopecia universalis and atopic dermatitis in a patient treated with a JAK inhibitor
- Transgenic Kallikrein 14 Mice Display Major Hair Shaft Defects Associated with Desmoglein 3 and 4 Degradation, Abnormal Epidermal Differentiation, and IL-36 Signature
- Evaluation of serum levels of IL-6, IL-10, and TNF-a in alopecia areata patients: A systematic review and meta-analysis
- Exploring the effect of hsa-miR-19b-3p on IL-1R1 expression and serum levels in alopecia areata
- Cepharanthine Inhibits Doxorubicin-Induced Cellular Senescence by Activating Autophagy via the mTOR Signaling Pathway
- Under Development JAK Inhibitors for Dermatologic Diseases
- CXCL12+ dermal fibroblasts promote neutrophil recruitment and host defense by recognition of IL-17
- Regulatory Effects of Thai Rice By-Product Extracts from Oryza sativa L. cv. Bue Bang 3 CMU and Bue Bang 4 CMU on Melanin Production, Nitric Oxide Secretion, and Steroid 5α-Reductase Inhibition
- Phosphodiesterase (PDE) Inhibitors for the Treatment of Inflammatory Skin Conditions
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
- Evidence of Heterogeneity and Quantitative Differences of the Type 1 5α-Reductase Expression in Cultured Human Skin Cells – Evidence of its Presence in Melanocytes
- Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt/mTOR signaling
- A Comprehensive Literature Review of JAK Inhibitors in Treatment of Alopecia Areata
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence